Han Yusheng 4
4 · Burning Rock Biotech Ltd · Filed Apr 2, 2026
Research Summary
AI-generated summary of this filing
Burning Rock Biotech (BNR) Director Han Yusheng Buys 314,870 ADS
What Happened
Han Yusheng, a director of Burning Rock Biotech Ltd (BNR), purchased 314,870 American depositary shares (ADS) on 2026-03-31 at a weighted average price of $17.36 per ADS, for a reported total of $5,466,143. This was an outright purchase (Form 4 code P), which investors often view as a more informative signal than routine sales.
Key Details
- Transaction date: 2026-03-31; Form 4 filed 2026-04-02 (appears timely).
- Reported weighted-average price: $17.36 per ADS; total value reported: $5,466,143.
- Price range: purchases occurred in multiple trades at prices between $16.10 and $18.99 (reporting person will provide breakdown on request).
- Shares purchased: 314,870 ADS. One ADS represents ten Class A ordinary shares, so this equals approximately 3,148,700 underlying ordinary shares.
- Shares owned after transaction: not specified in the provided filing excerpt.
- Footnotes: F1 notes the 1 ADS = 10 Class A shares conversion; F2 notes the weighted-average price and multi-trade price range and that a full per-price breakdown is available upon request.
Context
- These are direct open-market purchases of ADS (not option exercises or awards).
- For retail investors, ADS purchases represent direct insider buying of the company’s underlying ordinary shares; the filing does not explain motive.
- No indication in the provided excerpt that the filing was late or that this transaction involved a 10b5-1 plan, gifts, or tax-withholding.
Insider Transaction Report
Form 4
Han Yusheng
Director
Transactions
- Purchase
Ordinary Shares (represented by American depositary shares)
[F1][F2]2026-03-31$17.36/sh+314,870$5,466,143→ 17,672,676 total
Footnotes (2)
- [F1]One American depositary share represents ten Class A ordinary shares.
- [F2]The price reported is the weighted average price of American depositary shares. These American depositary shares were purchased in multiple transactions at prices ranging from $16.10 to $18.99. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Signature
/s/ Yuheng Huang, Attorney-in-Fact for Yusheng Han|2026-04-02